XML 43 R30.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Mezzanine and Stockholders’ Equity (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2018
Warrants Outstanding | The Company’s outstanding warrants consisted of the following:
|  | Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value |
Warrants outstanding at January 1, 2017 |  |  | 3,648,541 |  | $ | 9.75 |  |  | 3.74 |  | $ | 14.25 |
Warrants granted |  |  | - |  |  | - |  |  | - |  |  | - |
Warrants exercised |  |  | (191,625) |  |  | 7.55 |  |  | - |  |  | 9.96 |
Warrants expired/forfeited |  |  | (11,250) |  |  | - |  |  | - |  |  | - |
Warrants outstanding at March 31, 2018 |  |  | 3,445,666 |  | $ | 9.88 |  |  | 3.69 |  | $ | 6.07 |
|  |  |  |  |  |  |  | Weighted |
|  |  |  | Weighted |  |  |  | Average |
|  |  |  | Average |  |  |  | Exercise Price |
Exercise Price Per |  | Warrants |  | Remaining |  | Warrants |  | Per |
Share |  | Outstanding |  | Contractual Life |  | Exercisable |  | Share |
$ | 4.50 |  |  | 24,000 |  |  | 0.60 |  |  | 24,000 |  | $ | 4.50 |
| 9.00 |  |  | 1,116,111 |  |  | 2.53 |  |  | 1,116,111 |  |  | 9.00 |
| 10.00 |  |  | 1,455,555 |  |  | 4.05 |  |  | 1,455,555 |  |  | 10.00 |
| 11.00 |  |  | 850,000 |  |  | 4.69 |  |  | 850,000 |  |  | 11.00 |
$ | 4.50 –11.00 |  |  | 3,445,666 |  |  | 3.69 |  |  | 3,445,666 |  | $ | 9.88 |
Contracted physicians and other services [Member] |
Stock Option Transactions Under Stock Option Plans | Share-based compensation expense related to option awards granted to primary care physicians to purchase shares of APC’s common stock, recognized over their respective vesting periods, consisted of the following:
Three Months Ended March 31, |  | 2018 |  | 2017 |
Contracted physicians and other services |  | $ | 202,382 |  | $ | 321,233 |
Exclusivity Amendment Agreement, APC [Member] |
Stock Option Transactions Under Stock Option Plans | Outstanding stock options granted to primary care physicians to purchase shares of APC’s common stock consisted of the following:
|  | Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value |
Options outstanding at January 1, 2018 |  |  | 853,800 |  | $ | 0.167 |  |  | 1.75 |  | $ | 508,864 |
Options granted |  |  | - |  |  | - |  |  | - |  |  | - |
Options exercised |  |  | - |  |  | - |  |  | - |  |  | - |
Options expired/forfeited |  |  | - |  |  | - |  |  | - |  |  | - |
Options outstanding at March 31, 2018 |  |  | 853,800 |  | $ | 0.167 |  |  | 1.50 |  | $ | 508,864 |
Options exercisable at March 31, 2018 |  |  | 853,800 |  | $ | 0.167 |  |  | 1.50 |  | $ | 508,864 |
Employee Stock Option [Member] |
Stock Option Transactions Under Stock Option Plans | The Company’s outstanding stock options consisted of the following:
|  | Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value |
Options outstanding at January 1, 2018 |  |  | 1,141,040 |  | $ | 3.95 |  |  | 5.79 |  | $ | 19.81 |
Options granted |  |  | 30,000 |  |  | 9.25 |  |  | - |  |  | - |
Options exercised |  |  | (129,536) |  |  | 6.11 |  |  | - |  |  | 15.03 |
Options forfeited |  |  | - |  |  | - |  |  | - |  |  | - |
Options outstanding at March 31, 2018 |  |  | 1,041,504 |  | $ | 4.09 |  |  | 5.66 |  | $ | 11.86 |
Options exercisable at March 31, 2018 |  |  | 1,041,504 |  | $ | 4.09 |  |  | 5.66 |  | $ | 11.86 |

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5047-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=ameh_ContractedPhysiciansAndOtherServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ameh_AmendmentAgreementAxis=ameh_ExclusivityAmendmentAgreementApcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |